| Literature DB >> 34120419 |
Jae Jung Lee1,2, Seung Kwon Choi1,2, Han Jo Kwon1,3, Seung Min Lee1,3, Sung Who Park1,2, Ik Soo Byon1,2, Ji Eun Lee1,4.
Abstract
PURPOSE: To describe the development of multiple retinal hemorrhages after uncomplicated macular hole (MH) surgery, and to determine the associated factors.Entities:
Keywords: Brilliant blue G; Retinal hemorrhage; Retinal perforation; Vitrectomy; Vitreous detachment
Year: 2021 PMID: 34120419 PMCID: PMC8200588 DOI: 10.3341/kjo.2020.0124
Source DB: PubMed Journal: Korean J Ophthalmol ISSN: 1011-8942
Fig. 1Representative case from the retinal hemorrhage group. (A) Ultra-widefield fundus photograph of a patient with an idiopathic macular hole before surgery with no other specific finding. (B) A few clusters of retinal hemorrhages in the midperiphery are noted on the widefield fundus photograph acquired the day after uncomplicated macular hole surgery, using Brilliant Blue G stain and a room-air tamponade. (C) After 4 days, the gas bubble remains in less than half of the vitreous cavity, and multiple retinal hemorrhages are clearly observed. (D) The retinal hemorrhages have all resolved at 1 month after the surgery.
Fig. 2Various findings of multiple retinal hemorrhages after macular hole surgery. (A,B) Whitening of the retinal vessels (arrows) and (C,D) a central white core, which resembles Roth’s spot (arrows), are noted in conjunction with multiple retinal hemorrhages.
Fig. 3Changes in visual acuity after macular hole surgery. Visual acuity significantly improved after macular hole surgery (p < 0.001) in both groups. At 1 and 3 months after the surgery, no statistically significant differences in visual acuity were observed between the hemorrhage and no hemorrhage groups. logMAR = logarithm of the minimum angle of resolution.
Comparison of baseline characteristics, surgical methods, and systemic factors
| Hemorrhage group (n = 31) | No hemorrhage group (n = 136) | ||
|---|---|---|---|
| Age (yr) | 64.8 ± 7.1 | 65.4 ± 10.4 | 0.746 |
| Male : female | 11 : 20 | 47 : 89 | >0.999 |
| Underlying disease | |||
| Hypertension | 8 (25.8) | 51 (37.5) | 0.298 |
| DM | 2 (6.5) | 21 (15.4) | 0.255 |
| Cardiac disease | 1 (3.2) | 11 (8.1) | 0.698 |
| Renal disease | 3 (9.7) | 6 (4.4) | 0.370 |
| Liver disease | 0 (0) | 6 (4.4) | 0.594 |
| Anti-platelet medication | 1 (3.2) | 14 (10.3) | 0.309 |
| Laterality (right : left) | 14 : 17 | 67 : 69 | 0.696 |
| Visual acuity | 0.601 | ||
| Median (Snellen) | 20 / 100 | 20 / 100 | |
| Mean (logMAR) | 0.72 ± 0.32 | 0.76 ± 0.35 | |
| Hole size (μm) | 472.4 ± 196.4 | 441.4 ± 203.2 | 0.241 |
| Surgical induction of PVD (+ / −) | 30 / 1 | 101 / 35 | 0.004 |
| ILM peeling : ILM flap technique | 7 : 24 | 59 : 77 | 0.041 |
| ILM staining (BBG : TA) | 31 : 0 | 108 : 28 | 0.003 |
| Vitreous tamponade (air : 18% SF6) | 31 : 0 | 129 : 7 | 0.351 |
| Preoperative SBP (mmHg) | 121.9 ± 13.8 | 119.3 ± 12.6 | 0.310 |
| Preoperative DBP (mmHg) | 73.6 ± 8.4 | 74.5 ± 8.6 | 0.569 |
| Postoperative SBP (mmHg) | 119.4 ± 16.1 | 122.9 ± 13.2 | 0.193 |
| Postoperative DBP (mmHg) | 73.6 ± 10.2 | 76.2 ± 9.2 | 0.161 |
| Laboratory findings | |||
| Hb (g/dL) | 13.6 ± 1.1 | 13.5 ±1.4 | 0.800 |
| WBC (103/μL) | 6.5 ± 2.0 | 6.2 ± 1.7 | 0.500 |
| Platelet (103/μL) | 255.6 ± 68.6 | 255.7 ± 63.4 | 0.989 |
| AST : ALT ratio | 1.1 ± 0.3 | 1.2 ± 0.3 | 0.192 |
| T. Chol (mg/dL) | 195.9 ± 43.6 | 187.8 ± 40.6 | 0.326 |
| BUN : Cr ratio | 22.2 ± 7.1 | 20.9 ± 6.9 | 0.345 |
| PT time (sec) | 11.3 ± 0.6 | 11.4 ± 1.0 | 0.505 |
| aPTT time (sec) | 31.5 ± 4.3 | 32.6 ± 7.8 | 0.461 |
Values are presented as mean ± standard deviation, number (%) unless otherwise indicated.
DM = diabetes mellitus; logMAR = logarithm of the minimum angle of resolution; PVD = posterior vitreous detachment; ILM = internal limiting membrane; BBG = Brilliant Blue G; TA = triamcinolone acetonide; SF6 = sulfur hexafluoride; SBP = systolic blood pressure; DBP = diastolic blood pressure; Hb = hemoglobin; WBC = white blood cell; AST = aspartate aminotransferase; ALT = alanine aminotransferase; T. Chol = total cholesterol; BUN = blood urea nitrogen; Cr = creatinine; PT = prothrombin; aPTT = activated partial thromboplastin.
p < 0.05 was considered statistically significant.
Multiple regression analysis of factors associated with the development of multiple retinal hemorrhages
| OR | 95% CI | ||
|---|---|---|---|
| Surgical induction of PVD (+ / −) | 13.099 | 1.709–100.389 | 0.013 |
| ILM peeling : ILM flap technique | 1.358 | 0.438–4.208 | 0.596 |
| ILM staining (BBG : TA) | NA | NA | 0.998 |
OR = odds ratio; CI = confidence interval; PVD = posterior vitreous detachment; ILM = internal limiting membrane; BBG = Brilliant Blue G; TA = triamcinolone acetonide; NA = not applicable.
p < 0.05 was considered statistically significant.
Fig. 4Fluorescein angiography findings of multiple retinal hemorrhages after macular hole surgery. (A) Multiple retinal hemorrhages are noted in a 65-year-old male 6 days after macular hole surgery. (B) Fluorescein angiography reveals blocked fluorescence at the sites of hemorrhage, without leakage or non-perfusion. (C) Multiple blot hemorrhages are observed in the area temporal to the macula (arrows). (D) Blocked fluorescence is noted at the sites of hemorrhage (arrows). (E) The hemorrhages are almost completely resolved at six weeks after surgery (arrows).